As regulatory authorities like EFSA tighten restrictions on monacolin K even at low doses, traditional red yeast rice products are facing increased scrutiny. This is the time that you can shine your product in the next few years!
ANKASCIN® 568 is your future-proof solution—no monacolin K, no statin-like side effects, and fully compliant with both current and upcoming regulations.
| Ankascin 568 | Traditional Red Yeast Rice | |
|---|---|---|
| Active compounds | Monascin and Ankaflavin | Monacolin K |
| Safety | Free of Monacolin K | diabetes, muscle soreness, and liver and kidney damage |
| Clinically Proven | 5 Clinical Trial Publications | Unknown |
| Fermentation method | Automated Solid state fermentation | Small-scale fermentation |
| Patent | 20+ Global Patents | Unknown |
| SCI Publication | 140 SCI Publications | Unknown |
| Mechanism | Monascin and ankaflavin help reduce cholesterol levels by inhibiting its absorption and enhancing its breakdown in the body. | Monacolin K helps to inhibit the synthesis of cholesterol by blocking the action of HMG-CoA reductase enzyme in the liver. |
| Extra Benefits |
Maintains Healthy TC and LDL Maintains Healthy Triglyceride and HDL Maintains Healthy Blood Sugar Maintains Healthy Blood Pressure |
Maintains Healthy TC and LDL |
| Regulatory Status | Apply for EU and USA Regulation | EU: Restrict Monacolin K Content (Less than 3mg) USA: 0 mg Canada: 1 mg |
In a randomized, double-blind clinical study of the effects of ANKASCIN® 568, serum cholesterol was reduced by 11.9% after four weeks of supplementation with ANKASCIN® 568 and LDL-C was reduced by 19%. *Liu SF, Wang YR, Shen YC, et al. A randomized, double-blind clinical study of the effects of Ankascin 568 plus on blood lipid regulation. J Food Drug Anal. 2018;26(1):393-400.
In a randomized, double-blind human clinical study, fasting blood glucose was significantly reduced by 8.5% after just 6 weeks of taking ANKASCIN® 568 and by 9.3% after 12 weeks of use.⁴ *Wang YR, Liu SF, Shen YC, et al. A randomized, double-blind clinical study to determine the effect of ANKASCIN 568 plus on blood glucose regulation. J Food Drug Anal. 2017;25(2):409-416.
In a clinical trial, subjects in the test group had a significantly reduced systolic (SBP) and diastolic blood pressure (DBP) following 4 weeks of administration, and results were maintained until the end of the 8-week period. *Chen CL, Tseng JH, Pan TM, Hsiao SH. A Randomized, Double-Blind Clinical Study on Blood Pressure Reduction and Blood Lipid Profile Amelioration on Treatment with Ankascin 568. Chin J Physiol. 2017 Jun 30;60(3):158-165.
“Ankascin 568-P corresponds to the traditional preparation of red yeast rice. Therefore, this preparation is compliant with the current European Regulations, since the product, in addition to respecting the traditional manufacturing process of classical red yeast rice preparations, does not provide any monacolin. Therefore, Ankascin 568-P can be used in the European market.”
— FoodChain ID Compliance Report
“Your notification states that the new dietary ingredient is a red yeast fermented product extracted from Monascus purpureus that you call “ANKASCIN 568-R.” According to your amended notification, the conditions of use are: “For adults, take 0.11 g (per capsule) once or twice a day, with water after a meal. Take 0.1 lg (per capsule) once or twice a day, with water aftera meal. The product is safe for long-term consumption.”
— US FDA Notification Report
My doctor encouraged me to take a more proactive approach to my health, especially when it came to managing cholesterol and supporting balanced blood sugar. After taking Ankascin Red Rice for three months, I feel more energetic throughout the day, and I’m glad to have found a natural option that fits into my daily routine.
My 72-year-old mother had been feeling a bit low in energy and less steady in her daily routine. After starting ANKASCIN 568 Red Yeast, she says she feels more balanced and has more stamina throughout the day. It’s given her added confidence in supporting her heart and metabolic wellness.
I’ve always been mindful of my heart health, especially when dealing with daily stress. After taking this supplement for about six weeks, I’ve felt more balanced and steady throughout the day. It’s helped me feel more in control, and I appreciate the extra support for my cardiovascular wellness under pressure.
We got this for my auntie, who was looking for a natural way to support healthy lipid metabolism. After two months, she mentioned feeling lighter and more active overall, which really motivated her to stay consistent with her daily wellness routine.
As global regulators like EFSA tighten restrictions on monacolin K—even at trace levels—traditional red yeast rice products are facing growing regulatory uncertainty.
ANKASCIN® 568 offers a proven, future-ready solution: no monacolin K, no statin-like side effects, and full compliance with current and emerging global standards.
In a nutraceutical world that demands innovation, safety, and scientific validation, ANKASCIN® 568 gives your brand the power to lead with confidence.
As regulators like EFSA continue to restrict monacolin K—even at trace levels—traditional red yeast rice formulas face increasing uncertainty.
ANKASCIN® 568 offers a clean, compliant alternative: no monacolin K, no statin-like side effects, and no regulatory compromise.
If you’re ready to formulate for the future, start with a smarter ingredient—built for what’s next.